Intellipharmaceutics Announces Significant Advance in Its Abuse-Deterrent Oxycodone Program

Intellipharmaceutics Announces Significant Advance in Its Abuse-Deterrent Oxycodone Program
TORONTO — Intellipharmaceutics International Inc. today announced that it has achieved a significant advance in its program to develop and manufacture drugs incorporating abuse-deterrent characteristics.

Read more on GlobeNewswire via Yahoo! Finance

More Meth Drug Addiction Info: